Bortezomib

CAS 179324-69-7

Overview

Boltezomib is an anti-cancer drug used to treat multiple myeloma and mantle cell lymphoma. This includes those who have not been treated before and multiple myeloma. It is commonly used in combination with other drugs. It is given by injection

Anant Labs manufacture and furnish high quality Bortezomib impurities for global markets. Our Bortezomib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Bortezomib

Cat. No. ANTPRD4631Old No. ANT-BTZ-00CAS 179324-69-7In Stock

Technical Data

New Cat. No.ANTPRD4631

Old Cat. No.ANT-BTZ-00

CAS179324-69-7

Mol. FormulaC₁₉H₂₅BN₄O₄

Mol. Weight384.24 g/mol

IUPAC[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid

SMILESB([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O

InChIInChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1

InChI KeyGXJABQQUPOEUTA-RDJZCZTQSA-N

Synonyms

[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acidBortezomib179324-69-7VelcadePS-341LDP-341NSC-681239LDP 341Bortezomib accord69G8BD63PP